Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

638.35INR
30 Jan 2015
Change (% chg)

Rs-1.40 (-0.22%)
Prev Close
Rs639.75
Open
Rs641.95
Day's High
Rs645.00
Day's Low
Rs634.10
Volume
17,498
Avg. Vol
56,053
52-wk High
Rs906.90
52-wk Low
Rs630.00

Search Stocks
Ipca Laboratories Limited is an India-based pharmaceutical company. The Company has manufacturing over 350 formulations and 80 APIs for various therapeutic segments. Its formulations basket includes generics for the developed markets and branded formulations for emerging markets. It manufactures over 350 formulations in virtually every dosage form: oral solids and liquids, dry powders for suspension, and injectables. The Company’s manufactured APIs include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Furosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive) and Pyrantel Salts (anthelmintic). The Company has brands in 5 therapeutic areas, with 4 of its branded formulations. The Company’s products are exported to approximately 130 countries across the world and in diversified markets, such as Africa, Australia, Asia, Europe and the United States.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links

Search Stocks